JDD December Issue Highlights: From Plaque Psoriasis to CBD Gel
The December issue of the Journal of Drugs in Dermatology focuses on a variety of topics ranging from plaque psoriasis and infantile hemangioma to suturing wounds under tension and cannabinoid gel on sensitive dry skin. And an incredible line-up of articles to finish 2020 strong! Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Oxytocin Levels Inversely Correla …
The December issue of the Journal of Drugs in Dermatology focuses on a variety of topics ranging from plaque psoriasis and infantile hemangioma to suturing wounds under tension and cannabinoid gel on sensitive dry skin. And an incredible line-up of articles to finish 2020 strong! Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Oxytocin Levels Inversely Correla … Continue reading "JDD December Issue Highlights: From Plaque Psoriasis to CBD Gel"
Below are the issue highlights for the September issue of the JDD.
Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers … 
With the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi … 
Psoriasis involves a complex inflammatory cascade mediated by various cytokine effectors. Over the past fifteen years, treatment options have evolved to include biologic medications that provide targeted inhibition of various pathways. IL-23 has emerged as an important inflammatory cytokine in the pathogenesis of psoriasis. We continue our series, Therapeutic Cheat Sheet, with a closer look at IL- … 
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients. In this installment of our Therapeutic Cheat Sheet series, we’ll cover everything you need to know to start and monitor your patients on IL-17 blocking therapies.
[caption id="attachment_8301" align="alignleft" width="612"] Click image to en … 